Adaptive Biotechnologies (NASDAQ: [[ticker:ADPT]]) has appointed Mark Adams to serve as its chief technical officer. He was most recently managing director of healthcare advanced analytics at SVB Leerink. Adams is succeeding Sean Nolan, who will remain at Seattle-based Adaptive, taking on a new role as distinguished engineer. Adaptive is developing therapies based on insight into the adaptive immune system. Last year, the company raised $300 million from its IPO.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
